Group 1 - The core viewpoint of the news is that Zhejiang Sitaili Pharmaceutical Co., Ltd. has seen a significant increase in its stock price, with a rise of 5.33% to 11.06 CNY per share, and a total market capitalization of 4.849 billion CNY [1] - The company specializes in the production and sales of non-ionic iodine contrast agents and quinolone raw materials, with the contrast agent series accounting for 79.73% of its main business revenue [1] - The company was established on September 15, 1997, and went public on March 9, 2016 [1] Group 2 - Xiangcai Fund has a significant holding in Sitaili, with its Xiangcai Medical Health Mixed A Fund increasing its stake by 473,300 shares, bringing the total to 659,300 shares, which represents 10.01% of the fund's net value [2] - The fund has achieved a year-to-date return of 43.27%, ranking 1631 out of 8148 in its category [2] - The fund manager, Zhang Quan, has been in charge for 1 year and 318 days, with the best return during his tenure being 66.19% [3]

Core Viewpoint - The stock of Zhejiang Sitaili Pharmaceutical Co., Ltd. experienced a 6.12% increase, reaching 12.65 CNY per share, with a total market capitalization of 5.546 billion CNY as of September 15 [1] Group 1: Company Overview - Zhejiang Sitaili Pharmaceutical Co., Ltd. was established on September 15, 1997, and went public on March 9, 2016 [1] - The company specializes in the production and sales of non-ionic iodine contrast agent raw materials and quinolone raw materials [1] - The revenue composition of the company includes: contrast agents 79.73%, other supplementary products 10.19%, other 6.16%, CMO/CDMO 2.41%, and quinolone series 1.52% [1] Group 2: Fund Holdings - One fund, Xingye Healthcare A (011466), holds a significant position in Sitaili, with 1.8991 million shares, accounting for 4.83% of the fund's net value, making it the sixth-largest holding [2] - The fund has achieved a year-to-date return of 36.14% and a one-year return of 49.23%, ranking 1872 out of 8246 and 3177 out of 8054 in its category, respectively [2] - The fund manager, Chen Xu, has been in position for 4 years and 193 days, with a total fund size of 385 million CNY [2]